Join us in Ljubljana on 3 June 2026 for the GeneH & 21st CFGBC Scientific Symposium: “From Functional Genomics to Gene Therapy.” Free admission, registration open until 20 May.
📍 Faculty of Medicine, University of Ljubljana
shorturl.at/rBCS8
#GeneH #CFGBC #GeneTherapy #FunctionalGenomics
🚨 APPLICATION DEADLINE EXTENDED! 🚨
You now have until April 17th to apply for the GeneTherapy Accelerator.
Don't miss this specialized program designed to move #GeneTherapy research into clinically and commercially viable solutions.🧬
🔗Apply today: forms.office.com/e/eRWZ2kdz3q
#GeneH #HorizonEurope
🧬 RRA LUR is the Regional Development Agency of Ljubljana Urban Region that connects 25 municipalities of the region. In GeneH, RRA LUR strengthens the 4-Helix network and supports policy and stakeholder engagement to help accelerate translation to practice. → uc.pt/en/geneh/
@kemijski.bsky.social
⏳ LAST CALL!
Applications for the #GeneTherapyAccelerator are closing soon. Only 10 teams will be selected to accelerate their innovation.
📅 Program starts April 22nd.
Don’t miss out 🔗 forms.office.com/e/eRWZ2kdz3q
Learn more: tinyurl.com/genehpt
#GeneH #GeneTherapy #HorizonEurope
🧬🇸🇮 Rare Disease Day in Slovenia: the 12th National Conference connected researchers, clinicians, patients, decision makers and GeneH partners to discuss challenges and faster routes from science to care. Read more: www.uc.pt/en/geneh/new...
Got questions? 🤔
🔹 Format: Blended (approx. 8h/week). 🔹 Teams: Max 10 teams. 🔹 Focus: Dedicated to #GeneTherapy translation.
Ready to take the next step? Learn more:https://tinyurl.com/genehpt
#GeneH #GeneTherapyAccelerator #HorizonEurope
@kemijski.bsky.social
@ctgct.bsky.social
What will you achieve in 4 weeks? 📋 Each team will develop:
✅IP Roadmap. ✅Validated Business Model. ✅Regulatory & Product Roadmap. ✅Investor-ready Pitch Deck.
Real tools for real impact. 🚀
Apply by April 3. 🔗
tinyurl.com/genehpt
#GeneH #GeneTherapy #GeneTherapyAccelerator #HorizonEurope
🧬 ZOPS (Society helix) represents 45+ patient associations in Slovenia. It strengthens patient engagement and connects patient groups, clinicians and decision-makers. → uc.pt/en/geneh/
#ZOPS
@kemijski.bsky.social @ctgct.bsky.social
4 weeks to market readiness. 📈 Our intensive program covers:
🔹W1: Innovation Pathways. 🔹W2: Regulatory (ATMPs). 🔹W3: Business Strategy. 🔹W4: Pitch.
Finish with a Demo Day to showcase your project!
Apply now! 🔗 forms.office.com/e/eRWZ2kdz3q
#GeneH #GeneTherapy #GeneTherapyAccelerator #HorizonEurope
🤝The #GeneTherapyAccelerator connects you to a "Quadruple Helix" network:
Academic, Industry, Clinical, and Policy experts from the #GeneH consortium. 🌐
Access the mentorship you need to succeed.
Apply by April 3! 🔗 forms.office.com/e/eRWZ2kdz3q
#GeneTherapy #HorizonEurope
@kemijski.bsky.social
🧬 APAHE supports people affected by hereditary ataxias in Portugal, plus families and caregivers. In GeneH, APAHE brings lived-experience insight to strengthen awareness, genetic literacy and patient-centred, ethical approaches. → uc.pt/en/geneh/
@kemijski.bsky.social
@ctgct.bsky.social
Are you a pioneer in #GeneTherapy? 🔬 We are looking for:
1️⃣ Academic researchers. 2️⃣ Early-stage startups & spin-offs. 3️⃣ Clinical innovators.
Bridge the gap between lab research and clinical impact.
Apply here: forms.office.com/e/eRWZ2kdz3q 🔗
#GeneH #GeneTherapyAccelerator #HorizonEurope
ULS Coimbra provides integrated, people-centred healthcare and promotes innovation in care delivery. In GeneH, they bring the clinical perspective needed for real-world translation and implementation readiness of advanced therapies.
@kemijski.bsky.social
@ctgct.bsky.social
🧬 We are launching the #GeneTherapyAccelerator, a #GeneH initiative to translate breakthrough research into market-ready therapies.
Save the dates: 📅 April 22 & 29 📅 May 6 & 13
🔗 Apply now: forms.office.com/e/eRWZ2kdz3q
#GeneTherapy #HorizonEurope
@kemijski.bsky.social
@ctgct.bsky.social
🧬 CCDR Centro is the public authority coordinating regional development in Portugal’s Centro Region.
In GeneH, they help align policy priorities and stakeholders to strengthen the ecosystem and enable sustainable collaboration and real-world uptake.
@kemijski.bsky.social
@ctgct.bsky.social
🧠 The Blood–Brain Barrier protects the brain, but also blocks out many medicines. In GeneH Deliverable 5.1, our Joint Research Program advances precision of genetic tools and smart delivery strategies to reach CNS cells. Article: www.uc.pt/en/geneh/new...
@kemijski.bsky.social
@ctgct.bsky.social
SIH EEIG is a lighthouse for the innovation ecosystem, guiding stakeholders from ideas to pilots and uptake. They bridge the “valley of death” by translating ideas into real solutions. In GeneH, they coordinate ecosystems and partnerships.
uc.pt/en/geneh/
@kemijski.bsky.social
@ctgct.bsky.social
Presenting a summary of the Gene Therapy Landscape Analysis conducted by the GeneH Consortium, with EATRIS support. It maps the ecosystem across technology, regulation, ethics and society, and highlights what supports responsible gene therapy development in Europe.
www.uc.pt/en/geneh/new...
Presenting a summary of the Gene Therapy Landscape Analysis conducted by the GeneH Consortium, with EATRIS support. It maps the ecosystem across technology, regulation, ethics and society, and highlights what supports responsible gene therapy development in Europe.
www.uc.pt/en/geneh/new...
Success for #GeneH is a stronger 4-helix ecosystem, closer PT–SI collaboration and concrete examples of gene therapy innovations moving towards patients.
🎥 New video out now: youtu.be/DSkV0_tDEzM
#ResearchToPatients #EUProjects
@kemijski.bsky.social
@ctgct.bsky.social
GENEH partner ➡️ IPN is an innovation institute & incubator.
📌Competences: tech transfer, incubation, IP/ regulatory/ market pathways.
📌Role in GeneH: leads a 4-week Joint Innovation program &mentoring; Demo Day to convert GT concepts into validated business cases.
GeneH partners published a new article on Action & Investment Plan. 4-stage roadmap from Discovery → Testing → Scaling up → Clinical trials + tools.
Read more: www.uc.pt/en/geneh/new...
#GeneH #GeneTherapy #HorizonEurope #RareDiseases
@kemijski.bsky.social
@ctgct.bsky.social
GeneH partner (industry helix) ➡️ BioSistemika.
Building digital lab solutions, implement integrations, and support digital transformation of laboratories and regulated environments.
They contribute to implementation of digital tools in GeneH.
@kemijski.bsky.social
@ctgct.bsky.social
Biocant (Industry helix): biotech park & ecosystem combining incubation, NGS and microbiology with links to University labs. Acts as a connective hub for capability scouting and pipeline mapping within GeneH.
More about GeneH project→ www.uc.pt/en/geneh/
@kemijski.bsky.social
@ctgct.bsky.social
🤝Lead partner: University of Coimbra
📌CIBB/CNC-UC/GeneT:vector engineering, RNA/cell therapies, gene editing, disease modeling, ATMP regulatory expertise
☑️Advancing safer, more effective gene therapy while moving SCA3 research toward clinical translation and stronger clinical-trial interfaces.
Bluepharma (Industry helix): CRDMO enabling formulation-to-GMP transitions. Advanced Therapies Hub for mRNA delivery and a new sterile unit (dual lines) support flexible clinical-supply strategies within GeneH.
→ www.uc.pt/geneh/
@kemijski.bsky.social
@ctgct.bsky.social
JAFRAL joins GeneH’s Industry helix: CDMO for phages, plasmid DNA, mRNA. GMP clean rooms, fill-and-finish, QA/QC and CMC packages enable GMP-ready materials for tox and early clinical use—supporting GeneH translation.
→ www.uc.pt/geneh/
@kemijski.bsky.social
@ctgct.bsky.social
Gene therapy represents a shift from treating symptoms to addressing the genetic roots of disease. In #geneh video, partners talk about why gene therapy gives real hope for rare and chronic conditions, and why ethics, inclusiveness and data matter just as much as science: youtu.be/xf2UMZe0TYA
Meet KI –@kemijski institut. As one of GeneH’s key research pillars, KI (via @CTGCT) turns research into GMP-ready steps and safety evidence, advancing CTNNB1 & Kleefstra toward clinical readiness with EU partners.
👉 www.uc.pt/geneh/
@kemijski.bsky.social
@ctgct.bsky.social
During #CTGCTDays2025, the GENE H Conference – Gene Therapy covered genome editing, biosafety, and neuro-focused applications. UC/GeneT presented SCA3 strategies (allele-specific silencing & gene inactivation). Program& abstracts: ctgct.si/en/ctgct-day...
@kemijski.bsky.social
@ctgct.bsky.social